Xcout Intel
Coherus BioSciences competitors & alternatives
The 12 closest competitors and alternatives to Coherus BioSciences among biotech companies — ranked by similarity to what Coherus BioSciences actually does, not by market-cap band.
Subscribe to see Coherus BioSciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Coherus BioSciences
Coherus BioSciences, Inc. is a biopharmaceutical company headquartered in Redwood City, California, focused on oncology and developing innovative therapeutics.
Coherus BioSciences at a glance
Coherus BioSciences is a biotech company headquartered in United States. It has raised at least $126.8M across the 4 funding rounds on record. Its most recent funding round raised $6.8M in December 2017. Xcout tracks 21 named people at Coherus BioSciences, including Dennis M Lanfear (President & Chief Executive Officer). Xcout recorded 11 job postings from Coherus BioSciences in the last 90 days.
Coherus BioSciences leadership
- Dennis M LanfearPresident & Chief Executive Officer
- Bryan McMichaelChief Financial Officer
- Andy RittenbergChief Legal Officer
- Arvind SoodChief Strategy and Corporate Affairs Officer
- Rebecca SunshineChief Human Resources Officer
- Rosh Dias, M.D., M.R.C.P.Chief Medical Officer
15 more named people on record for Coherus BioSciences, with roles, board committees and tenure — see the full roster →
Coherus BioSciences funding rounds
At least $126.8M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $6.8M | — | |
| SEC Form D filing | $10M | — | |
| Series C | $55M | 3 named | |
| Series A | $55M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Coherus BioSciences
Xcout recorded 11 job postings from Coherus BioSciences in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Coherus BioSciences's hiring signals →
Top 12 Coherus BioSciences competitors
Ranked by semantic similarity — how close each company is to Coherus BioSciences by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Trellis Bioscience, Inc. is a clinical-stage biotechnology company located in Redwood City, California, focused on developing antibody-based therapeutics.
Biotechnology
VelosBio Inc. is a clinical-stage biopharmaceutical company based in California, United States, focused on developing novel antibody-drug conjugates to transform cancer treatment for patients.
Biotechnology
Hinge Bio, Inc. is a privately held biotechnology company headquartered in Redwood City, California, leveraging its GEM-DIMER platform to design and develop therapeutics for cancer as well as autoimmune and inflammatory diseases.
Biotechnology
Curon Biopharmaceutical is a clinical-stage biotechnology company developing antibody-based medicines, including bispecific antibodies, for cancer and other serious diseases. It serves patients and healthcare providers through the development of therapeutic biologics, with programs intended for oncology and immunology applications.
Biotechnology
Revolution Medicines is a biotechnology research company headquartered in Redwood City, California. Its mission is to revolutionize treatment for patients with RAS-addicted cancers through targeted medicines, translating frontier oncology targets.
Similar biotech company
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm specializing in the development and commercialization of immuno-oncology therapies. Their leading investigational compound, Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, is currently progressing through Phase Ib/II clinical trials for the treatment of non-small cell lung cancer and head and neck cancers. Another promising candidate, CPI-818, functions as a covalent ITK inhibitor. This therapy is undergoing Phase I/Ib clinical evaluation for patients battling various malignant T-cell lymphomas, aiming to impede the proliferation of specific malignant T-cells. Additionally, Ciforadenant (CPI-444), an oral, small molecule antagonist of the A2A receptor, is in Phase II clinical trials for individuals diagnosed with either advanced or refractory renal cell carcinoma. Beyond these clinical-stage assets, Corvus maintains a preclinical portfolio including CPI-182, an antibody designed to block inflammation and myeloid suppression, and CPI-935, an adenosine A2B receptor antagonist intended to prevent fibrosis. The company also benefits from a strategic collaboration with Angel Pharmaceuticals, which aids in advancing its diverse pipeline of targeted experimental drugs. Founded in 2014, Corvus Pharmaceuticals is headquartered in Burlingame, California.
Biotechnology
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing transformative technology platforms and first-in-class T-cell therapies to access cancer-specific targets.
Similar biotech company
Amgen Inc. is an American multinational biopharmaceutical and biotechnology company headquartered in Thousand Oaks, California. The company focuses on discovering, developing, manufacturing, and delivering innovative medicines to address severe diseases.
Similar biotech company
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Biotechnology
Cleave Biosciences, Inc. is a biotechnology research company headquartered in California, focused on discovering and developing novel therapies that target protein homeostasis to treat cancer.
Biotechnology
Curis, Inc. is a biotechnology company headquartered in Lexington, Massachusetts. The company is engaged in the research and development of drug candidates for the treatment of human cancers.
Biotechnology
Coherent Biopharma is a biotechnology research and pharmaceutical company founded by Robert Huang. Headquartered in Suzhou, China, the firm focuses on targeted protein degradation and advanced drug discovery in oncology and biotherapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Coherus BioSciences and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Coherus BioSciencesand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →